Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Genaissance Pharmaceuticals Inc.

Headquarters: New Haven, CT, United States of America
Website: N/A
Year Founded: 1997
Status: Out of Business

BioCentury | Feb 7, 2011
Product Development

Keep It Simple

Clinical Data depression drug approved on new dosing regimen, not biomarkers
BioCentury | Jan 24, 2011
Clinical News

Viibryd vilazodone regulatory update

BioCentury | Dec 6, 2010
Company News

Clinical Data, Transgenomic deal

BioCentury | May 31, 2010
Finance

Regulatory milestones

Highlights of weekly biotech stock moves
BioCentury | May 31, 2010
Clinical News

Vilazodone regulatory update

BioCentury | May 25, 2010
Company News

FDA accepts vilazodone NDA

BioCentury | Mar 29, 2010
Clinical News

Vilazodone regulatory update

BioCentury | Jun 8, 2009
Clinical News

Vilazodone: Phase III data

BioCentury | Dec 17, 2007
Company News

Clinical Data, Merck KGaA deal

BioCentury | Nov 19, 2007
Clinical News

Vilazodone: Phase III start

Items per page:
1 - 10 of 114